Related Practice Life Sciences & Pharma In light of new data surrounding the impact of COVID-19 on the population, health services, pharmaceutical industry and wider economy, L.E.K.’s Healthcare team is releasing regular updates on the rapidly evolving landscape. 01262022170144
Smart Chart Life Sciences & Pharma Look Forward 2025: Proving AI’s Value in Life Sciences January 22, 2025
Published Articles Sustainability To Meet Decarbonization Targets, Master The Circular Economy July 9, 2024
Podcast Life Sciences & Pharma Scope 3 Emissions: A Strategic Imperative for Pharma Companies May 8, 2024
Case Study Life Sciences & Pharma Cost and Reimbursement Assessment for a Biopharmaceutical Company May 7, 2024 A large biopharmaceutical company developing chimeric antigen receptor T-cell (CAR-T) therapies
Article Diagnostics, Tools and Personalized Medicine A New Generation of Drug Therapies Requires New Business Strategies April 29, 2024
Special Report Biotech and Pharmaceuticals Scope 3 Emissions: A Strategic Imperative for Pharma Companies March 19, 2024